Viewing Study NCT03379493


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-02-26 @ 2:16 AM
Study NCT ID: NCT03379493
Status: TERMINATED
Last Update Posted: 2019-02-04
First Post: 2017-12-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma
Sponsor: Eureka Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module